Parascript Announces New Version, Implementations of AccuDetect Computer-Aided Detection for Digital Mammography

ParascriptParascript, LLC, the image analysis and pattern recognition technology provider, today announced the latest version of its computer-aided detection (CAD) technology for mammography. AccuDetect 6.1 offers radiologists continued improvements in sensitivity and specificity in detecting suspicious lesions on mammograms.

Parascript® AccuDetect® is intended for use in screening mammography to identify suspicious areas for breast cancer. The technology can help to prompt closer examination of a potential lesion that a radiologist may have overlooked in an initial read. Digital mammography images are automatically analyzed to identify suspicious areas for possible soft tissue densities and/or calcifications and enable a more accurate interpretation of mammograms.

AccuDetect 6.1 uses proprietary pattern recognition and image processing technology to detect the presence of suspicious lesions on mammogram images and is even more robust, with significantly higher performance compared to the previous version. The result is a state-of-the-art CAD product with high sensitivity and low false-positive rates.

It is available in Europe to digital mammography equipment vendors to integrate with DR (direct radiography) and CR (computer radiography) systems.

"At Parascipt, we are very optimistic about the advances that have been made in AccuDetect 6.1. We remain tireless in our commitment to further our technology and are extremely excited about being able to help in the fight against breast cancer," said Yuri Prizemin, director of business development for medical imaging for Parascript.

AccuDetect 6.1 has been installed in France, Germany and Sweden on CR and DR systems.

About Parascript, LLC
The Parascript image analysis suite extracts meaningful information from images. Employing patented digital image analysis and pattern recognition technologies, the Parascript image analysis suite improves decision quality in medical imaging, postal and payment automation, fraud detection and forms processing operations. Parascript software processes billions of documents per year. Fortune 500 companies, postal operators, major government and financial institutions rely on Parascript products. Organizations include the U.S. Postal Service, Bell + Howell, Fiserv, Elsag, Lockheed Martin, NCR, Siemens and Burroughs. Parascript is online at http://www.parascript.com.

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...